Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
Orexin
FDA
Narcolepsy
Alkermes
Takeda
Biogen
Alnylam
Biotechnology
Biotech Sector
Cedar
Pfizer
Stoke
Xenon
China
Clinical Trials
RNA Interference
AI In Biotech
Duchenne Muscular Dystrophy
Axsome Therapeutics
Peanut Allergy

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes336Founded10 months ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

Co-Founder and CEO Daniel Getts walks us through the platform, which is delivered via LNPs. The lead programs target TROP2, HER2, and GPC3.

CEO James Field and CSO Angus Sinclair discuss the Nectin-4 bi-specific, which is meant to have increased selectivity and potency and will compete with ADCs that are already on the market. Plus, how they are using their ML/AI expertise to help Sanofi... more

Founder and CEO Michelle Lee highlights the key distinction between Medra and other automated lab equipment, which is that Medra's platform is designed to sense and understand its environment and use that knowledge to make its own intelligent decisio... more

He talks about Kymera's dosing methodology, and recaps the data from a degredation, biomarker, and clinical outcomes standpoint. Plus, next steps in STAT6, and thoughts on the platform in general and the field more broadly.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Kevin Friedman
CEO of Kelonia Therapeutics
Kelonia Therapeutics
Episode: ASH 2025: Kelonia Therapeutics presented convincing late-breaking data at ASH today from its initial patients in multiple myeloma suggesting that in vivo CAR-T is on track to be a next innovation
Nadim Ahmed
CEO of Cullinan Therapeutics
Cullinan Therapeutics
Episode: ASH 2025: Cullinan Therapeutics CEO Nadim Ahmed highlights the company's FLT3xCD3 bispecific T-cell engager data at ASH in AML and MDS
Paul Rennert
CSO of Aleta Biotherapeutics
Aleta Biotherapeutics
Episode: ASH 2025: Aleta Biotherapeutics' Paul Rennert shares the company's first clinical data for its CAR-T cell engager program that is meant to increase the density of CD19 on B-cell malignancies.
Will West
Co-founder and CEO of CellCentric
CellCentric
Episode: ASH 2025: CEO Will West describes how CellCentric is seeing results for its oral p300/CBP inhibitor, Inobrodib, in heavily refractory multiple myeloma patients
John Quisel
CEO of Disc Medicine
Disc Medicine
Episode: ASH 2025: Disc Medicine CEO John Quisel walks us through the RALLY-MF Phase 2 trial data of DISC-0974 in anemia of myelofibrosis
Nate Fernhoff
Co-founder and CEO of Orca Bio, discussing cell therapy
Orca Bio
Episode: ASH 2025: Orca Bio has an April 6th PDUFA date from FDA for its cell therapy product, Orca-T, that aims to solve the problem of treatment-related toxicities that come with stem cell transplants
Ken Galbraith
Chief Executive of Zymeworks
Zymeworks
Episode: Jefferies London: Zymeworks had double-news during London Life Science Week - a P3 success for its HER2 bispecific in gastroesophageal cancer and it also launched a new royalty model
John Olyer
Founder, Chairman and CEO of BeOne Medicines
BeOne Medicines
Episode: Jefferies London: BeOne Medicines announced a phase 3 success for its HER2 bispecific today in gastric cancer. John Olyer walks us through that and the whole pipeline
Chris Roop
Head of M&A for the Americas and joint head of Global Biopharma at Jefferies
Jefferies
Episode: Jefferies London: Jefferies M&A Banker Chris Roop shares his take on the environment for deals in biotech

Hosts

Brad
Host discussing biotech news and developments, with extensive experience in reporting within the biotech industry.
Amy
Host of BiotechTV's coverage, providing insightful commentary on biotech advancements.
Kendalle Burlin O'Connell
President and CEO of MassBio, sharing insights and perspectives on the biotech sector.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

ASH 2025: Von Willibrand disease is the most common bleeding disorder, though many people have never heard of it. Star Therapeutics is working on a solution that is already in phase 3
Q: What could go wrong? What are the risks of a phase 3 study like that?
The risks would primarily relate to safety and tolerability of the product, but so far, the safety profile appears clean and promising.
ASH 2025: Von Willibrand disease is the most common bleeding disorder, though many people have never heard of it. Star Therapeutics is working on a solution that is already in phase 3
Q: What does a win look like in this study, and what's the timeline of it and all of that?
A win would mean showing a 50% reduction in annualized bleeding rates, and the phase 3 study is designed to collect data over several months before transitioning patients to treatment.
ASH 2025: Nurix CEO Arthur Sands discusses his company's BTK degrader data at ASH, and highlights the benefits of degraders more broadly in oncology and I&I
Q: Is the future of BTK degraders going to be a replacement for traditional BTK drugs?
Yes, we think the degradation mechanism can ultimately displace virtually all inhibitors across oncology.
ASH 2025: Ascentage Pharma Chairman & CEO Dajun Yang shares an update on the company's Bcl-2, lisaftcoclax, which was recently approved in China and is in multiple global registration studies
Q: What are the timelines for the trials you are currently running?
We aim to finish the enrollment for GLORA next year and get quicker enrollment for MDS patients due to the lack of options.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

Content revolves around developments in the biotechnology sector, including insights on clinical trials, groundbreaking therapies, and innovations related to drug development. Episodes frequently feature interviews with industry leaders discussing their companies' latest products and scientific advancements. The emphasis on practical applications and real-world implications of biotech innovations aims to provide listeners with a comprehensive understanding of ongoing changes and opportunities within the life sciences landscape. Unique elements include on-site reporting from key biotech events and conferences, allowing for timely and relevant coverage of industry trends.

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. BioCentury This Week
3. The Readout Loud
4. Cheeky Pint
5. All-In with Chamath, Jason, Sacks & Friedberg

How many episodes of BiotechTV are there?

BiotechTV launched 10 months ago and published 336 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Kevin Friedman
2. Nadim Ahmed
3. Paul Rennert
4. Will West
5. John Quisel
6. Nate Fernhoff
7. Ken Galbraith
8. John Olyer

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days